Hadváry P, Lengsfeld H, Wolfer H
F. Hoffmann-La Roche & Co., Ltd., Pharmaceutical Research Department, Basel, Switzerland.
Biochem J. 1988 Dec 1;256(2):357-61. doi: 10.1042/bj2560357.
Tetrahydrolipstatin inhibits pancreatic lipase from several species, including man, with comparable potency. The lipase is progressively inactivated through the formation of a long-lived covalent intermediate, probably with a 1:1 stoichiometry. The lipase substrate triolein and also a boronic acid derivative, which is presumed to be a transition-state-form inhibitor, retard the rate of inactivation. Therefore, in all probability, tetrahydrolipstatin reacts with pancreatic lipase at, or near, the substrate binding or active site. Tetrahydrolipstatin is a selective inhibitor of lipase; other hydrolases tested were at least a thousand times less potently inhibited.
四氢脂抑素能抑制包括人类在内的多种物种的胰脂肪酶,其效力相当。脂肪酶通过形成一种可能具有1:1化学计量比的长寿命共价中间体而逐渐失活。脂肪酶底物三油酸甘油酯以及一种被认为是过渡态形式抑制剂的硼酸衍生物会延缓失活速率。因此,很可能四氢脂抑素在底物结合位点或活性位点处或其附近与胰脂肪酶发生反应。四氢脂抑素是一种脂肪酶的选择性抑制剂;所测试的其他水解酶受到的抑制效力至少低一千倍。